We are live on ! Find out more
AG

Advisor Group Portfolio holdings

AUM $14.5B
1-Year Est. Return 24.86%
This Fund
S&P 500
This Quarter Est. Return
-11.22%
1 Year Est. Return
+24.86%
3 Year Est. Return
+39.54%
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$266M
Cap. Flow
+$1.6B
Cap. Flow %
15.75%
Top 10 Hldgs %
19.6%
Holding
5,482
New
237
Increased
2,510
Reduced
1,723
Closed
201

Sector Composition

Rank Sector Weight
1 Technology 5.26%
2 Financials 4.59%
3 Healthcare 4.15%
4 Consumer Discretionary 3.48%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDC
4601
DELISTED
Rowan Companies Plc
RDC
$4K ﹤0.01%
430
-8,807
-95% -$129K
SGYP
4602
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$4K ﹤0.01%
34,514
-12,200
-26% -$8.01K
LALT
4603
DELISTED
Invesco Multi-Strategy Alternative ETF
LALT
$4K ﹤0.01%
177
PAF
4604
DELISTED
Invesco FTSE RAFI Asia Pacific ex-Japan ETF
PAF
$4K ﹤0.01%
90
-918
-91% -$46K
NYV
4605
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
$4K ﹤0.01%
+300
New +$4K
CNY
4606
DELISTED
Market Vectors-Renminbi
CNY
$4K ﹤0.01%
100
NIHD
4607
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$4K ﹤0.01%
813
+345
+74% +$1.91K
EVJ
4608
DELISTED
Eaton Vance New Jersey Municipal Income Trust
EVJ
$4K ﹤0.01%
355
CPI
4609
DELISTED
CPI Inflation Hedged ETF
CPI
$4K ﹤0.01%
161
-158
-50% -$4.33K
AGRO icon
4610
Adecoagro
AGRO
$1.53B
$3K ﹤0.01%
500
AMTX icon
4611
Aemetis
AMTX
$119M
$3K ﹤0.01%
+5,000
New +$4.35K
ASMB icon
4612
Assembly Biosciences
ASMB
$506M
$3K ﹤0.01%
10
-5
-33% -$1.45K
ATHE
4613
Alterity Therapeutics
ATHE
$82.3M
$3K ﹤0.01%
251
ATKR icon
4614
Atkore
ATKR
$2.59B
$3K ﹤0.01%
+144
New +$3.01K
AVXL icon
4615
Anavex Life Sciences
AVXL
$222M
$3K ﹤0.01%
+2,000
New +$4.54K
STEX
4616
Streamex Corp
STEX
$76.7M
$3K ﹤0.01%
68
+20
+42% +$877
BZH icon
4617
Beazer Homes USA
BZH
$907M
$3K ﹤0.01%
+340
New +$3.38K
CARM
4618
DELISTED
Carisma Therapeutics
CARM
$3K ﹤0.01%
100
CDLX icon
4619
Cardlytics
CDLX
$21M
$3K ﹤0.01%
28
CHT icon
4620
Chunghwa Telecom
CHT
$33.2B
$3K ﹤0.01%
85
CIO
4621
DELISTED
City Office REIT
CIO
$3K ﹤0.01%
271
+171
+171% +$1.91K
CRBN icon
4622
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
$3K ﹤0.01%
29
CRMD icon
4623
CorMedix
CRMD
$617M
$3K ﹤0.01%
400
CSTM icon
4624
Constellium
CSTM
$3.96B
$3K ﹤0.01%
495
+209
+73% +$1.86K
HERZ
4625
Herzfeld Credit Income Fund
HERZ
$33M
$3K ﹤0.01%
+74
New +$3.27K

Similar funds

Advisor Group's Q4 2018 Portfolio in Review

As of Q4 2018, Advisor Group held 5,482 positions worth $10.2B, up 2.7% from $9.92B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Advisor Group deployed $1.6B of net new capital in Q4 2018, opening 237 new positions and adding to 2,510 existing holdings. Its largest new stake was AnaptysBio: 122,700 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 6.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $61M trimmed.

  • Advisor Group's largest Q4 2018 buy was AnaptysBio: 122,700 shares worth $7.83M.
  • Advisor Group added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $134M increase.
  • Advisor Group's biggest Q4 2018 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $61M.
  • Advisor Group fully exited Corporate Capital Trust, Inc. in Q4 2018, selling an estimated $12.1M.
  • Advisor Group's ten largest holdings make up 20% of its $10.2B portfolio in Q4 2018.
  • Advisor Group opened 237 new positions and closed 201 in Q4 2018.
  • Advisor Group's portfolio value rose 2.7% quarter-over-quarter to $10.2B.

Based on Advisor Group's 13F filing for Q4 2018, filed 11 Feb 2019.